tiprankstipranks
Pharmaxis Ltd (AU:PXS)
ASX:PXS

Pharmaxis Ltd (PXS) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Pharmaxis Ltd’s (PXS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pharmaxis Ltd is a Sell.
Pharmaxis Ltd’s (PXS) 20-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (PXS) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (PXS) 50-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (PXS) share price is <AU$0.1, making it a Sell.

Pharmaxis Ltd (PXS) Pivot Points

May 04, 2024, 12:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Fibonacci
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaxis Ltd (PXS) Moving Averages

May 04, 2024, 12:16 AM
Period
Simple
Exponential
MA5
0.03Buy
0.03Sell
MA10
0.03Buy
0.03Sell
MA20
0.03Sell
0.03Sell
MA50
0.03Sell
0.03Sell
MA100
0.04Sell
0.04Sell
MA200
0.04Sell
0.04Sell
Pharmaxis Ltd’s (PXS) 10-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (PXS) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (PXS) 100-Day exponential moving average is 0.04, while Pharmaxis Ltd’s (PXS) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (PXS) stock price is <AU$0.1 and Pharmaxis Ltd’s (PXS) 50-day simple moving average is 0.03, creating a Sell signal.
Pharmaxis Ltd’s (PXS) stock price is <AU$0.1 and Pharmaxis Ltd’s (PXS) 100-day simple moving average is 0.04, creating a Sell signal.
Pharmaxis Ltd’s (PXS) stock price is <AU$0.1 and Pharmaxis Ltd’s (PXS) 200-day simple moving average is 0.04, creating a Sell signal.

Pharmaxis Ltd (PXS) Technical Indicators

May 04, 2024, 12:16 AM
Name
Value
Implied Action
RSI (14)
46.16
Neutral
STOCH (9,6)
63.33
Neutral
STOCHRSI (14)
58.89
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
16.86
Buy
Williams %R
-33.33
Buy
CCI (14)
-273.68
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
73.95
Buy
ROC
0.00
-
Pharmaxis Ltd’s (PXS) Relative Strength Index (RSI) is 46.16, creating a Neutral signal.
Pharmaxis Ltd’s (PXS) Trend Strength Indicator (ADX) is 16.86, creating a Buy signal.
Pharmaxis Ltd’s (PXS) Commodity Channel Index (CCI) is -273.68, creating a Buy signal.

FAQ

Is PXS a Buy, Hold, or Sell?
Based on PXS’s technical indicators, PXS is a Sell.
    What is PXS’s RSI (14)?
    PXS’s RSI (14) is 46.16, which suggests PXS is a Neutral.
      What is PXS’s MACD?
      PXS’s MACD is >-0.01, which suggests PXS is a Sell.
        What is PXS’s 5-day moving average?
        PXS’s 5-day moving average is 0.03, which suggests PXS is a Buy.
          What is PXS’s 20-day moving average?
          PXS 20-day moving average is 0.03, which suggests PXS is a Sell.
            What is PXS’s 50-day moving average?
            PXS’s 50-day moving average is 0.03, which suggests PXS is a Sell.
              What is PXS’s 200-day moving average?
              PXS’s 200-day moving average is 0.04, which suggests PXS is a Sell.
                What is PXS’s Williams % R (14)?
                PXS’s Williams % R (14) is -33.33, which suggests PXS is a Buy.
                  What is PXS’s CCI (14)?
                  PXS’s CCI (14) is -273.68, which suggests PXS is a Buy.
                    What is the share price of Pharmaxis Ltd?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis